Health News Archive - May 21, 2010
This Saturday, May 22nd, at James Braddock Park in North Bergen, NJ Walk Led by Award-Winning Journalist Geraldo Rivera TEANECK, N.J., May 21 /PRNewswire-USNewswire/ -- For the first time in its 85-year history, Holy Name Medical Center has launched a fundraising initiative with its newly founded Hispanic Outreach Program called Walk for HOPE, a walkathon designed to promote cancer prevention awareness to Hispanic men and women.
PHOENIX, May 21 /PRNewswire/ -- The Alzheimer's Association released a report on Wednesday, May 19, predicting that the cost of Alzheimer's disease over the next 40 years would reach $20 trillion if newer treatments are not on the horizon. "Today, there are no treatments that can prevent, delay, slow or stop the progression of Alzheimer's disease," noted Harry Johns, President and CEO of the Alzheimer's Association.
In a study published May 20 in the journal Addiction, researchers have determined that treatment for smoking dependence is as effective among people with severe mental illnesses as it is for the general population.
BETHESDA, Md., May 21 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today reported results for the three months ended March 31, 2010. Recent and Upcoming Highlights D-Tagatose as a Treatment for Type 2 DiabetesThe phase 3 efficacy trial will complete very soon (Q3 2010), following the successful conclusion of enrollment in January 2010Announced encouraging blinded interim Phase 3 clinical trial data that suggested a reduction in variability of HbA1c levels, the primary endpoint of the trialReported positive preliminary interim Phase 2 (Dose Range) clinical trial data suggesting a dose-proportional reduction of HbA1c levels using various doses of D-tagatose lower than the dose used in the current Phase 3 trialConducted a second round of Medical Advisory Board meetings to provide clinical guida
WASHINGTON, May 21 /PRNewswire-USNewswire/ -- The Health Alliance of Greater Cincinnati and one of its former member hospitals, The Christ Hospital, have agreed to pay the United States $108 million to settle claims that they violated the Anti-Kickback Statute and the False Claims Act by paying unlawful remuneration to doctors in exchange for referring cardiac patients to The Christ Hospital in a pay-to-play scheme, the Justice Department announced today.
PARIS, May 21 /PRNewswire/ -- LightLab Imaging, Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) technology for coronary and other imaging applications will showcase its C7-XR(TM) Imaging System and its companion C7 Dragonfly(TM) Imaging Catheter at EuroPCR 2010 in Paris, France on May 25 to 28, at booth M-12.
NEW BRAUNFELS, Texas, May 21 /PRNewswire/ -- The SCOOTER Store is supporting the Center for Medical Humanities & Ethics at the UT Health Science Center San Antonio, believing that teaching ethics and humanitarian values to future doctors and health professionals will encourage compassionate care for the nation's elderly. "The long-term goal of The SCOOTER Store is to create an opportunity for every American senior to live their entire life safely and confidently at home," said Mike Pfister, Executive Vice President of External Relations and Government Affairs at The SCOOTER Store.
NASHVILLE, Tenn., May 21 /PRNewswire/ -- Global Clinical Communications (GCC) has hired Marshall Graves as vice president of clinical solutions. GCC, a leading supplier of validated clinical research technology solutions and services for site activation and management, announces that Graves will lead the clinical solutions division, including the rapidly growing and popular Compass(TM) virtual workspace portal site activation and management software. Graves comes to GCC with a reputation as an expert in technology-based clinical research solutions, after many years of senior management in companies providing solutions for pharmaceutical clinical research.
SANTA BARBARA, Calif., May 21 /PRNewswire-FirstCall/ -- Abviva, Inc.
BOSTON, May 21 /PRNewswire-USNewswire/ -- Ortho-McNeil Pharmaceutical LLC, a subsidiary of Johnson & Johnson, pled guilty today in U.S.
- A person in a secondary role, specifically the second most important character (after the protagonist).